• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[细胞因子检测在眼部慢性移植物抗宿主病诊断中的临床研究]

[Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].

作者信息

Cheng X J, Ji R, Huan R H, Huang S Q, Fan W, Zhao Y C, Yuan R D, Wang X Q, Zhang X

机构信息

Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Micoenvironment, State Key Laboatory of Trauma and Chemical Poisoning, Chongqing 400037, China.

Department of Ophthalmology, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):242-248. doi: 10.3760/cma.j.cn121090-20231031-00242.

DOI:10.3760/cma.j.cn121090-20231031-00242
PMID:38716595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11078663/
Abstract

To investigate the association between cytokines and ocular chronic graft-versus-host disease (cGVHD) and identify specific biomarkers for ocular cGVHD to enhance clinical diagnosis, treatment, and evaluation. A mouse model of cGVHD was established to explore the correlation between cGVHD and serum cytokines. Based on the findings from the animal experiments and literature review, a panel of 16 cytokine combinations was identified. Enzyme-linked immunosorbent assay (ELISA) was used to compare the cytokine concentrations in the serum and tear samples from patients who underwent allogeneic hematopoietic stem cell transplantation from June 2017 to March 2022 at the Medical Center of Hematology, Xinqiao Hospital, Army Medical University. ① Compared with the control group, mice with cGVHD exhibited elevated serum IL-1β, IL-6, IL-8, IL-17, IFN-γ, CX3CL1, CXCL11, CXCL13, CCL11, and CCL19 concentrations (all <0.05). ② Analysis of the cytokine profiles of the serum and tear samples revealed that compared with patients without ocular cGVHD, those with ocular cGVHD exhibited increased serum IL-8 [=0.032, area under the curve (AUC) =0.678]; decreased serum IL-10 (=0.030, AUC=0.701) ; elevated IL-8, IFN-γ, CXCL9, and CCL17 in tear samples; and lower IL-10 and CCL19 in tear samples (all <0.05, all AUC>0.7). Moreover, cytokines in tear samples showed correlations with ocular surface parameters related to ocular cGVHD. Tear fluid demonstrates greater specificity and sensitivity as a biomarker for diagnosing ocular cGVHD than serum biomarkers. Among the identified cytokines in tear samples, IL-8, IL-10, IFN-γ, CXCL9, CCL17, and CCL19 serve as diagnostic biomarkers for ocular cGVHD post-transplantation, offering practical reference value for diagnosis.

摘要

为研究细胞因子与眼部慢性移植物抗宿主病(cGVHD)之间的关联,并确定眼部cGVHD的特异性生物标志物,以加强临床诊断、治疗及评估。建立cGVHD小鼠模型,以探索cGVHD与血清细胞因子之间的相关性。基于动物实验结果及文献综述,确定了一组16种细胞因子组合。采用酶联免疫吸附测定(ELISA)比较2017年6月至2022年3月在陆军军医大学新桥医院血液科医疗中心接受异基因造血干细胞移植患者血清和泪液样本中的细胞因子浓度。①与对照组相比,cGVHD小鼠血清白细胞介素-1β(IL-1β)、IL-6、IL-8、IL-17、干扰素-γ(IFN-γ)、CX3CL1、CXCL11、CXCL13、CCL11和CCL19浓度升高(均<0.05)。②血清和泪液样本的细胞因子谱分析显示,与无眼部cGVHD的患者相比,眼部cGVHD患者血清IL-8升高[=0.032,曲线下面积(AUC)=0.678];血清IL-10降低(=0.030,AUC=0.701);泪液样本中IL-8、IFN-γ、CXCL9和CCL17升高;泪液样本中IL-10和CCL19降低(均<0.05,所有AUC>0.7)。此外,泪液样本中的细胞因子与眼部cGVHD相关的眼表参数存在相关性。作为眼部cGVHD的生物标志物,泪液比血清生物标志物具有更高特异性和敏感性。在泪液样本中鉴定出的细胞因子中,IL-8、IL-10、IFN-γ、CXCL9、CCL17和CCL19可作为移植后眼部cGVHD的诊断生物标志物,为诊断提供实用参考价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a864/11078663/d4c7292c1356/cjh-45-03-242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a864/11078663/86dc7d31fa27/cjh-45-03-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a864/11078663/d4c7292c1356/cjh-45-03-242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a864/11078663/86dc7d31fa27/cjh-45-03-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a864/11078663/d4c7292c1356/cjh-45-03-242-g002.jpg

相似文献

1
[Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].[细胞因子检测在眼部慢性移植物抗宿主病诊断中的临床研究]
Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):242-248. doi: 10.3760/cma.j.cn121090-20231031-00242.
2
Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.眼部慢性移植物抗宿主病中的生物标志物:基于泪液细胞因子和趋化因子的预测模型。
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):746-58. doi: 10.1167/iovs.15-18615.
3
Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.泪液细胞因子作为慢性移植物抗宿主病的生物标志物
Biol Blood Marrow Transplant. 2015 Dec;21(12):2079-2085. doi: 10.1016/j.bbmt.2015.08.020. Epub 2015 Aug 22.
4
Longitudinal Tear Cytokine Biomarkers: An Analysis from the Close Assessment and Testing for Chronic Graft-Versus-Host Disease (CATCH) Protocol.纵向撕裂细胞因子生物标志物:来自慢性移植物抗宿主病密切评估与检测(CATCH)方案的分析。
Transplant Cell Ther. 2025 Apr;31(4):226.e1-226.e9. doi: 10.1016/j.jtct.2025.02.004. Epub 2025 Feb 7.
5
Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease.造血干细胞移植前泪液细胞因子作为眼部慢性移植物抗宿主病潜在易感性生物标志物
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4836-4846. doi: 10.1167/iovs.17-21670.
6
[The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].慢性移植物抗宿主病患者血清特异性生物标志物的临床观察
Zhonghua Xue Ye Xue Za Zhi. 2019 Nov 14;40(11):948-952. doi: 10.3760/cma.j.issn.0253-2727.2019.11.012.
7
Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.异基因干细胞移植后眼部移植物抗宿主病患者泪液中的细胞因子
Mol Vis. 2012;18:797-802. Epub 2012 Apr 1.
8
The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation.白细胞介素 6、白细胞介素 10 和肿瘤坏死因子-α 在同种异体移植后眼移植物抗宿主病中的作用。
Ocul Immunol Inflamm. 2024 Oct;32(8):1788-1795. doi: 10.1080/09273948.2024.2302445. Epub 2024 Jan 22.
9
Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.造血干细胞移植后口腔慢性移植物抗宿主病成人患者的口腔症状严重程度、健康相关生活质量和相关唾液细胞因子。
Biol Blood Marrow Transplant. 2010 Jul;16(7):948-956. doi: 10.1016/j.bbmt.2010.01.017. Epub 2010 Feb 6.
10
Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host Disease.泪液脂质代谢物作为眼部慢性移植物抗宿主病的潜在诊断生物标志物。
Transplant Cell Ther. 2021 Mar;27(3):232.e1-232.e6. doi: 10.1016/j.jtct.2020.12.018. Epub 2020 Dec 19.

本文引用的文献

1
Recent advances in ocular graft-versus-host disease.眼移植物抗宿主病的最新进展。
Front Immunol. 2023 Jan 25;14:1092108. doi: 10.3389/fimmu.2023.1092108. eCollection 2023.
2
[Treatment of chronic ocular graft versus host disease].[慢性眼部移植物抗宿主病的治疗]
Zhonghua Xue Ye Xue Za Zhi. 2022 Oct 14;43(10):877-880. doi: 10.3760/cma.j.issn.0253-2727.2022.10.015.
3
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.调节性 T 细胞的代谢特征及其对肿瘤微环境的适应:对抗肿瘤免疫的影响。
J Hematol Oncol. 2022 Aug 10;15(1):104. doi: 10.1186/s13045-022-01322-3.
4
Current status and prospects of hematopoietic stem cell transplantation in China.中国造血干细胞移植的现状与展望。
Chin Med J (Engl). 2022 Jun 20;135(12):1394-1403. doi: 10.1097/CM9.0000000000002235.
5
Tear Film Immunological Profile in Patients with Ocular Graft versus Host Disease.眼移植物抗宿主病患者的泪膜免疫特征。
Ocul Immunol Inflamm. 2023 May;31(4):701-709. doi: 10.1080/09273948.2022.2046794. Epub 2022 Apr 11.
6
Does CCL19 act as a double-edged sword in cancer development?CCL19 是否在癌症发展中充当双刃剑?
Clin Exp Immunol. 2022 Apr 4;207(2):164-175. doi: 10.1093/cei/uxab039.
7
[Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].《慢性移植物抗宿主病诊断与治疗中国专家共识(2021年版)》
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):265-275. doi: 10.3760/cma.j.issn.0253-2727.2021.04.001.
8
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.CXCR3 配体的多态性可预测 CXCL9 的早期恢复和严重的慢性移植物抗宿主病。
Blood Cancer J. 2021 Feb 27;11(2):42. doi: 10.1038/s41408-021-00434-2.
9
Involvement of ocular surface in graft-versus-host disease: An update from immunopathogenesis to treatment.移植物抗宿主病中眼表的参与:从免疫发病机制到治疗的更新。
J Cell Physiol. 2021 Sep;236(9):6190-6199. doi: 10.1002/jcp.30304. Epub 2021 Jan 28.
10
Transitional immature regulatory B cells and regulatory cytokines can discriminate chronic antibody-mediated rejection from stable graft function.过渡性未成熟调节性 B 细胞和调节性细胞因子可区分慢性抗体介导的排斥反应与稳定的移植物功能。
Int Immunopharmacol. 2020 Sep;86:106750. doi: 10.1016/j.intimp.2020.106750. Epub 2020 Jul 8.